MedTrace Logo

Methylation Analysis of Circulating Tumor DNA in Gastric Cancer

NCT04511559 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 540

Last updated 2020-08-13

No results posted yet for this study

Summary

The primary purpose of this trial is to describe the profile of ctDNA methylation in gastric cancer. The second purpose is to demonstrate the correlation between the plasma ctDNA methylation status and the diagnosis and prognosis of patients with early and intermediate stage gastric cancer.

Conditions

  • Stomach Neoplasms
  • Circulating Tumor DNA

Interventions

DIAGNOSTIC_TEST

Circulating Tumor DNA Methylation Sequencing

Whole blood collection through venipuncture. DNA methylation levels by deep sequencing.

DIAGNOSTIC_TEST

tissue DNA Methylation Sequencing

Isolate DNA from tissue samples from subjects. DNA methylation levels by deep sequencing.

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2023-09-30
Completion
2025-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04511559 on ClinicalTrials.gov